Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cullinan Therapeutics (CGEM) Assets (2020 - 2023)

Historic Assets for Cullinan Therapeutics (CGEM) over the last 4 years, with Q3 2023 value amounting to $494.7 million.

  • Cullinan Therapeutics' Assets fell 1985.14% to $494.7 million in Q3 2023 from the same period last year, while for Sep 2023 it was $494.7 million, marking a year-over-year decrease of 1985.14%. This contributed to the annual value of $561.1 million for FY2022, which is 2834.77% up from last year.
  • Per Cullinan Therapeutics' latest filing, its Assets stood at $494.7 million for Q3 2023, which was down 1985.14% from $522.0 million recorded in Q2 2023.
  • In the past 5 years, Cullinan Therapeutics' Assets ranged from a high of $667.2 million in Q2 2022 and a low of $214.7 million during Q4 2020
  • For the 4-year period, Cullinan Therapeutics' Assets averaged around $488.7 million, with its median value being $487.2 million (2021).
  • In the last 5 years, Cullinan Therapeutics' Assets surged by 10361.84% in 2021 and then tumbled by 2177.07% in 2023.
  • Cullinan Therapeutics' Assets (Quarter) stood at $214.7 million in 2020, then skyrocketed by 103.62% to $437.2 million in 2021, then grew by 28.35% to $561.1 million in 2022, then decreased by 11.84% to $494.7 million in 2023.
  • Its last three reported values are $494.7 million in Q3 2023, $522.0 million for Q2 2023, and $515.0 million during Q1 2023.